New inhibitors of histone deacetylase (HDAC) containing a sulfhydryl group were designed on the basis of the corresponding hydroxamic acid (CHAP31) and FK228. Their disulfide dimers and hybrids exhibited potent HDAC inhibitory activity in vivo with potential as anticancer prodrugs. [structure: see text]
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/ol036098e | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!